by Anna Hunt, Awareness Junkie

A judge out of New Jersey ruled that a man’s insurance company must pay for the cost of his medical cannabis treatment. This may establish an important precedent in the medical industry.

Andrew Watson, who lives in Egg Harbor, New Jersey, enrolled in the state’s medical cannabis program in 2014. He sought financial reimbursement for the purchase of medicinal cannabis over a term of three months.

Watson was injured on the job. Subsequently, he suffered from chronic neuropathic pain in his left hand. His condition was consistent with New Jersey’s list of qualifying conditions for medical marijuana. Yet, his initial worker’s compensation claim was denied.

During the hearing, a psychiatrist/neurologist testified on Watson’s behalf. The expert stated that medical marijuana would allow Watson to reduce his prescription opiate use. In addition, this would lower risk of addiction and dangerous side effects. The court established that Watson’s cannabis usage is indeed medicinal and that his insurance company should cover his claim.

The presiding judge, Ingrid L. French, stated:

Anna Hunt, Staff Writer
Waking Times

The newly-released cannabis pain patch targets seemingly unexplainable pain associated with fibromyalgia and diabetic neuropathy. It is a new-found hope for patients because it is extremely difficult to treat these conditions.

Cannabis Offers Hope for Better Quality of Life

Nerve pain is a debilitating symptom of many illnesses, including diabetes, fibromyalgia, celiac disease and multiple sclerosis. Pain associated with these ailments drastically reduces quality of life.

Take fibromyalgia for example:

“The National Institutes of Health estimates that 5 million Americans suffer from fibromyalgia, a poorly understood disorder characterized by deep tissue pain, fatigue, headaches, depression, and lack of sleep. There is no known cure and the disorder is difficult to treat.” (source)

by Kalee Brown, Collective Evolution

For years, Monsanto has been trying to hide the detrimental risks their leading herbicide, Roundup, poses to human health and the environment. Over the years, numerous studies have been published proving that the active ingredient in Roundup, glyphosate, can cause cancer, miscarriages, Parkinson’s disease, Alzheimer’s, and more.

Despite the overwhelming amount of evidence in support of the harmful effects of Roundup, Monsanto continues to monopolize the entire North American seed industry without government intervention. Roundup can be found all over any non-organic food, golf courses, and soil, despite the fact that it is a known carcinogen. However, thanks to a federal court judge in California, Monsanto may finally be tried for its wrongdoings and secrecy, shedding light on the truth about Roundup and the company’s ties to the U.S. government.